Gemmer Asset Management’s Abiomed Inc ABMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-68
| Closed | -$22K | – | 1246 |
|
|
2022
Q1 | $22K | Buy |
68
+2
| +3% | +$616 | ﹤0.01% | 476 |
|
|
2021
Q4 | $24K | Hold |
66
| – | – | ﹤0.01% | 467 |
|
|
2021
Q3 | $21K | Hold |
66
| – | – | ﹤0.01% | 468 |
|
|
2021
Q2 | $21K | Hold |
66
| – | – | ﹤0.01% | 522 |
|
|
2021
Q1 | $21K | Hold |
66
| – | – | ﹤0.01% | 505 |
|
|
2020
Q4 | $21K | Hold |
66
| – | – | ﹤0.01% | 441 |
|
|
2020
Q3 | $18K | Hold |
66
| – | – | ﹤0.01% | 431 |
|
|
2020
Q2 | $16K | Buy |
66
+24
| +57% | +$4.82K | ﹤0.01% | 451 |
|
|
2020
Q1 | $6K | Sell |
42
-23
| -35% | -$3.82K | ﹤0.01% | 720 |
|
|
2019
Q4 | $11K | Sell |
65
-99
| -60% | -$18.4K | ﹤0.01% | 636 |
|
|
2019
Q3 | $29K | Buy |
164
+22
| +15% | +$4.76K | 0.01% | 292 |
|
|
2019
Q2 | $37K | Sell |
142
-23
| -14% | -$6.1K | 0.01% | 236 |
|
|
2019
Q1 | $47K | Buy |
165
+100
| +154% | +$33.2K | 0.01% | 201 |
|
|
2018
Q4 | $21K | Buy |
65
+23
| +55% | +$7.99K | 0.01% | 346 |
|
|
2018
Q3 | $19K | Sell |
42
-38
| -48% | -$15K | 0.01% | 427 |
|
|
2018
Q2 | $33K | Hold |
80
| – | – | 0.01% | 259 |
|
|
2018
Q1 | $23K | Hold |
80
| – | – | 0.01% | 355 |
|
|
2017
Q4 | $15K | Hold |
80
| – | – | 0.01% | 560 |
|
|
2017
Q3 | $13K | Hold |
80
| – | – | ﹤0.01% | 570 |
|
|
2017
Q2 | $11K | Hold |
80
| – | – | ﹤0.01% | 622 |
|
|
2017
Q1 | $10K | Hold |
80
| – | – | ﹤0.01% | 670 |
|
|
2016
Q4 | $9K | Buy |
80
+2
| +3% | +$232 | ﹤0.01% | 680 |
|
|
2016
Q3 | $10K | Hold |
78
| – | – | 0.01% | 619 |
|
|
2016
Q2 | $9K | Sell |
78
-1
| -1% | -$99 | ﹤0.01% | 629 |
|
|
2016
Q1 | $7K | Buy |
79
+6
| +8% | +$506 | ﹤0.01% | 717 |
|
|
2015
Q4 | $7K | Sell |
73
-7
| -9% | -$594 | ﹤0.01% | 726 |
|
|
2015
Q3 | $7K | Buy |
80
+32
| +67% | +$2.82K | ﹤0.01% | 695 |
|
|
2015
Q2 | $3K | Hold |
48
| – | – | ﹤0.01% | 1056 |
|
|
2015
Q1 | $3K | Buy |
48
+6
| +14% | +$326 | ﹤0.01% | 1094 |
|
|
2014
Q4 | $2K | Hold |
42
| – | – | ﹤0.01% | 1190 |
|
|
2014
Q3 | $1K | Hold |
42
| – | – | ﹤0.01% | 1333 |
|
|
2014
Q2 | $1K | Hold |
42
| – | – | ﹤0.01% | 1354 |
|
|
2014
Q1 | $1K | Buy |
+42
| New | +$1.16K | ﹤0.01% | 1340 |
|
Other funds holding ABMD
GIM
BCM
Gemmer Asset Management's ABMD Position: Q2 2022 in Review
Gemmer Asset Management sold out of Abiomed Inc (ABMD) in Q2 2022, closing a stake of 68 shares — an estimated $22K sold.
Gemmer Asset Management first reported a position in ABMD in Q1 2014 and held it in 33 quarters. The position peaked at $47K in Q1 2019. 496 funds tracked by Wall St. Rank hold ABMD as of Q2 2022.
- Gemmer Asset Management reported no remaining Abiomed Inc position as of Q2 2022 after selling out during the quarter.
- Gemmer Asset Management sold 68 Abiomed Inc shares in Q2 2022, an estimated $22K.
- Gemmer Asset Management first reported a position in Abiomed Inc in Q1 2014 and held it in 33 quarters.
- Gemmer Asset Management's Abiomed Inc position peaked at $47K in Q1 2019.
- 496 funds tracked by Wall St. Rank held Abiomed Inc as of Q2 2022.
Based on Gemmer Asset Management's 13F filing for Q2 2022, filed 22 Jul 2022.